RAPT Therapeutics

RAPT Therapeutics is a clinical-stage biopharmaceutical company focused on developing oral small molecule therapies to address significant unmet needs in inflammatory diseases and cancer. The company's scientific approach centers on modulating the immune system by targeting key drivers of inflammation and cancer. RAPT has two lead drug candidates: zelnecirnon (RPT193) for inflammatory disorders like eczema and asthma, and tivumecirnon (FLX475) for a broad range of cancers. Both drugs target the CCR4 receptor, which plays a key role in immune cell recruitment and activation.

RAPT is driven by a visionary leadership team with extensive experience in the pharmaceutical and biotechnology industries. The company is committed to rigorous scientific research, clinical development, and strategic partnerships. Its headquarters are located in South San Francisco, California, placing it at the heart of the global biotech community. With a focus on innovative therapies and a relentless pursuit of breakthroughs, RAPT Therapeutics aims to improve and empower countless lives by conquering inflammation and cancer.

RAPT Therapeutics values work-life balance and encourages employees to rejuvenate and share experiences with colleagues, friends, and family. They host quarterly events like BBQs, movie screenings, offsite retreats, and holiday parties, and they partner with local organizations to offer employee discounts on various activities. While specific details about flexible work arrangements aren't mentioned, the emphasis on work-life balance and employee well-being suggests a supportive environment for flexible work options.

RAPT Therapeutics offers a comprehensive benefits package to its employees, including competitive compensation, stock option grants, three weeks of paid vacation, free online legal services, employee assistance programs, and pre-tax flexible spending accounts for medical, dependent care, and commuter expenses. These benefits aim to provide a work-life balance and reward employees for their contributions to the company's success.

RAPT Therapeutics is a clinical-stage biopharmaceutical company committed to discovering and developing oral small molecule therapies that target key drivers of the immune system. Their mission is to treat inflammatory diseases and conquer cancer in our lifetime by developing innovative therapies that modulate critical immune responses, ultimately improving and empowering countless lives.

RAPT Therapeutics promotes a culture that values teamwork, open communication, and a fearless approach to innovation. They encourage employees to bring their whole selves to work and prioritize work-life balance. The company fosters a collaborative environment with regular team events, including BBQs, movie screenings, and holiday parties. Their values prioritize patient well-being, ethical conduct, and adapting to new challenges with a "one team" mindset.

RAPT Therapeutics is committed to fostering a diverse, equitable and inclusive workplace, emphasizing the importance of valuing diverse perspectives and backgrounds. They believe in creating a welcoming and supportive environment where all employees feel a sense of belonging and have the opportunity to reach their full potential. They are committed to attracting, developing and retaining a talented and diverse workforce, reflecting the communities they serve.